Article
A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes.
International journal of cancer - 10 Dec 1999
Morel S, Ooms A, Van Pel A, Wölfel T, Brichard V G, van der Bruggen P, Van den Eynde B J, Degiovanni G
Abstract excerpt
We previously described different cytotoxic T lymphocyte (CTL) clones isolated from the blood lymphocytes of a melanoma patient after in vitro stimulation with autologous tumor cells. These CTL clones recognized at least 2 distinct antigens on the melanoma cells. Here, we show that one of them consists of a peptide derived from tyrosinase and presented by HLA-B35. The peptide is 9 amino acids long and has the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
